GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 24-002_000 Universitair Medisch Centrum Utrecht Two clinical studies (Trials 1504-0001 and 1504-0003) with BI 3720931, a replication-deficient, self-inactivating, 3rd generation lentiviral vector gene therapy developed for inhaled treatment of cystic fibrosis 09-09-2024 Vergunning verleend
IM-MV 24-011_000 LUMC Lentiviral transduced human cells to treat human diseases Ontwerpbesluit genomen